Wild SH - Search Results

1

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.

Höhn A, Jeyam A, Caparrotta TM, McGurnaghan SJ, O'Reilly JE, Blackbourn LAK, McCrimmon RJ, Leese GP, McKnight JA, Kennon B, Lindsay RS, Sattar N, Wild SH, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group. Höhn A, et al. Among authors: wild sh. Diabetologia. 2021 Jun;64(6):1309-1319. doi: 10.1007/s00125-021-05394-7. Epub 2021 Feb 19. Diabetologia. 2021. PMID: 33608768 Free PMC article.

2

Mortality of women with polycystic ovary syndrome at long-term follow-up.

Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Pierpoint T, et al. Among authors: wild sh. J Clin Epidemiol. 1998 Jul;51(7):581-6. doi: 10.1016/s0895-4356(98)00035-3. J Clin Epidemiol. 1998. PMID: 9674665

3

Glycemic control and cardiovascular disease in type 2 diabetes: a review.

Wild SH, Dunn CJ, McKeigue PM, Comte S. Wild SH, et al. Diabetes Metab Res Rev. 1999 May-Jun;15(3):197-204. doi: 10.1002/(sici)1520-7560(199905/06)15:3<197::aid-dmrr28>3.0.co;2-f. Diabetes Metab Res Rev. 1999. PMID: 10441042 Review.

4

Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study.

Wild S, Pierpoint T, Jacobs H, McKeigue P. Wild S, et al. Hum Fertil (Camb). 2000;3(2):101-105. doi: 10.1080/1464727002000198781. Hum Fertil (Camb). 2000. PMID: 11844363 Free article.

5

Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.

Warren RE, Strachan MW, Wild S, McKnight JA. Warren RE, et al. Diabet Med. 2007 May;24(5):494-7. doi: 10.1111/j.1464-5491.2007.02118.x. Epub 2007 Mar 15. Diabet Med. 2007. PMID: 17367305

6

What is the scale of the future diabetes epidemic, and how certain are we about it?

Wild SH, Forouhi NG. Wild SH, et al. Diabetologia. 2007 May;50(5):903-5. doi: 10.1007/s00125-007-0647-7. Epub 2007 Mar 21. Diabetologia. 2007. PMID: 17375282 No abstract available.

7

Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study.

Wild S, Macleod F, McKnight J, Watt G, Mackenzie C, Ford I, McConnachie A, Lindsay RS. Wild S, et al. Diabet Med. 2008 Feb;25(2):194-9. doi: 10.1111/j.1464-5491.2008.02382.x. Diabet Med. 2008. PMID: 18290861

8

Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001-2006.

McKnight JA, Morris AD, Cline D, Peden N, Fischbacher C, Wild S; Scottish Diabetes Survey Monitoring Group. McKnight JA, et al. Diabet Med. 2008 Jun;25(6):743-6. doi: 10.1111/j.1464-5491.2008.02453.x. Diabet Med. 2008. PMID: 18544111

9

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Colhoun HM; SDRN Epidemiology Group. Colhoun HM, et al. Diabetologia. 2009 Sep;52(9):1755-65. doi: 10.1007/s00125-009-1453-1. Epub 2009 Jul 15. Diabetologia. 2009. PMID: 19603149 Free PMC article.

10

Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.

McKeigue PM, Campbell H, Wild S, Vitart V, Hayward C, Rudan I, Wright AF, Wilson JF. McKeigue PM, et al. Int J Epidemiol. 2010 Jun;39(3):907-18. doi: 10.1093/ije/dyp397. Epub 2010 Mar 25. Int J Epidemiol. 2010. PMID: 20348110 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters